2582
S.-L. Zhu et al. / Tetrahedron Letters 49 (2008) 2578–2582
C. J.; Im, K. S.; Jung, J. H. J. Nat. Prod. 2005, 68, 711; (c) Kouko, T.;
purified by recrystallization from EtOH–DMF (1:1) to afford (4a). 4-
(4-Chlorophenyl)-6-(1H-indol-3-yl)-3-methyl-1-phenyl-1H-pyrazolo[3,
4-b]pyridine-5-carbonitrile: Light yellow solid; mp: >300 °C; IR
(KBr): m 3303, 3063, 2971, 2199, 1613, 1481, 1304, 1234, 1041,
Matsumura, K.; Kawasaki, T. Tetrahedron 2005, 61, 2309; (d)
Kaniwa, K.; Arai, M. A.; Li, X.; Ishibashi, M. Bioorg. Med. Chem.
Lett. 2007, 17, 4254.
3. (a) Franco, L. H.; Joffe, E. B. K.; Puricelly, L.; Tatian, M.; Seldes, A.
M.; Palermo, J. A. J. Nat. Prod. 1998, 61, 1130; (b) Mohamed, A. A.;
Mahmound, El-S. Bioorg. Med. Chem. 2007, 15, 1206.
4. (a) Jiang, B.; Yang, C.-G.; Xiong, W.-N.; Wang, J. Bioorg. Med.
Chem. 2001, 9, 1149; (b) Gompel, M.; Leost, M.; Joffe’, E. B. K.;
Puricelli, L.; Franco, L. H.; Palermo, J.; Meijer, L. Bioorg. Med.
Chem. Lett. 2004, 14, 1703.
5. (a) Kawasaki, Y.; Yamashita, M.; Otha, S. J. Chem. Soc., Chem.
Commun. 1994, 2085; (b) Kawasaki, Y.; Yamashita, M.; Otha, S.
Chem. Pharm. Bull. 1996, 44, 1831.
6. Kawasaki, Y.; Katsuma, H.; Nakayama, Y.; Yamashita, M.; Otha, S.
Heterocycles 1998, 48, 1887.
740 cmꢀ1 1H NMR (400 MHz, DMSO-d6): d 11.92 (br s, 1 H, NH),
;
8.44–8.45 (m, 2H), 8.27 (d, J = 8.0 Hz, 2H), 7.73–7.74 (m, 4H), 7.62
(t, J = 7.6 Hz, 2H), 7.56 (d, J = 8.0 Hz, 1H), 7.42 (t, J = 7.2 Hz, 1H),
7.26 (t, J = 7.6 Hz, 1H), 7.20 (t, J = 7.6 Hz, 1H), 2.06 (s, 3H, CH3);
13C NMR (100 MHz, DMSO-d6): d 155.3, 151.2, 149.9, 143.6, 138.2,
136.3, 134.6, 132.7, 130.8, 129.4, 129.1, 128.5, 126.4, 125.7, 122.6,
121.4, 121.0, 120.9, 118.5, 112.6, 112.1, 111.4, 99.5, 14.3; HRMS
found: m/z 469.1265 (M+), calcd for C28H18N5Cl: M, 459.1251.
Preparation of compound 4a under conventional heating condition:
An equimolar (1 mmol) mixture of 3-cyanoacetyl indole 1, aldehyde 2,
and 5-amino-3-methyl-1-phenylpyrazol 3 was subsequently intro-
duced into a 25 mL flask, and stirred in 5 mL glycol at 150 °C (oil
7. Sun, H. H.; Sakemi, J. J. Org. Chem. 1991, 56, 4307.
8. Vervoort, H. C.; Richards-Gross, S. E.; Fenical, W.; Lee, A. Y.;
Clardy, J. J. Org. Chem. 1997, 62, 1486.
bath temperature) for a given time. The subsequent work-up
procedure was the same as in the microwave irradiation reactions.
Preparation of compound 5a. A mixture containing 3-cyanoacetyl
indole (1 mmol), 4-chlorobenzaldehyde (1 mmol), and glycol (2.0 mL)
was introduced into a 10 mL reaction vial and irradiated at the
maximum power of 250 W and 150 °C for 10 min. The reaction
mixture was allowed to cool to room temperature. The solid was
filtered and washed with water and EtOH (95%) to give pure product
5a. 3-(4-Chlorophenyl)-2-(1H-indole-3-carbonyl)acrylonitrile: Yellow
solid; mp: 224–225 °C; IR (KBr): m 3356, 3175, 3056, 2929, 2221, 1602,
1512, 1489, 1433, 1312, 1234, 1182, 1091, 1013, 867, 823, 751, 645,
9. Takahashi, S.; Matsunaga, T.; Hasegawa, C.; Saito, H.; Fujita, D.;
Kiuchi, F.; Tsuda, Y. Chem. Pharm. Bull. 1998, 46, 1527.
10. (a) N’Diaye, Y.; Guella, G.; Chiasera, G.; Mancini, Y.; Pietra, F.
Tetrahedron Lett. 1994, 50, 4147; (b) Guella, G.; Mancini, Y.;
N’Diaye, Y.; Pietra, F. Helv. Chim. Acta 1999, 77, 1994.
11. Bergmann, T.; Schories, D.; Steffan, B. Tetrahedron 1997, 53, 2055.
12. Kohmoto, S.; Kashman, Y.; McConnell, O. J.; Rinehart, K. L.;
Wright, A., Jr.; Koehn, F. J. Org. Chem. 1988, 53, 3116.
13. (a) Gein Stein, R.; Biel, J. H.; Singh, T. J. Med. Chem. 1979, 13, 153;
(b) Farghaly, A. M.; Habib, N. S.; Khalil, M. A.; El-Sayed, O. A.
Alexandria J. Pharm. Sci. 1989, 3, 90; (c) Gatta, F.; Pomponi, M.;
Marta, M. J. Heterocycl. Chem. 1991, 28, 1301.
527 cmꢀ1 1H NMR (400 MHz, DMSO-d6): d 12.39 (br s, 1H, NH),
;
8.46 (s, 1H, CH), 8.23 (s, 1H, Indolyl-H), 8.17 (d, J = 6.8 Hz, 1H,
Indolyl-H), 8.05 (d, J = 8.4 Hz, 2H, Ar-H), 7.68 (d, J = 8.4 Hz, 2H,
Ar-H), 7.55 (d, J = 7.2 Hz, 1H, Indolyl-H), 7.26–7.31 (m, 2H, Indolyl-
H); 13C NMR (100 MHz, DMSO-d6): d 181.2, 150.6, 136.9, 136.8,
136.3, 131.9, 131.4, 129.3, 126.1, 123.6, 122.5, 121.4, 117.5, 113.5,
112.6, 112.1; HRMS found: m/z 306.0564 (M+), calcd for
14. (a) Tietze, L. F. Chem. Rev. 1996, 96, 115; (b) Do¨mling, A.; Ugi, I.
Angew. Chem., Int. Ed. 2000, 39, 3169.
15. (a) Weber, L. Drug Discovery Today 2002, 7, 143; (b) Do¨mling, A.
Curr. Opin. Chem. Biol. 2002, 6, 306.
C
18H11N2OCl: M, 306.0560.
16. Sun, C.; Ji, S.-J. Tetrahedron Lett. 2007, 48, 8987.
Preparation of compound 7b. In a 10 mL EmrysTM reaction vial, 3-
cyanoacetyl indole (1 mmol), 4-chlorobenzaldehyde (1 mmol), naph-
thalen-1-amine 6 (1 mmol) and glycol (2 mL) were mixed and then
capped. The mixture was irradiated for the given time at the
maximum power of 250 W and 150 °C. Upon completion, monitored
by TLC, the reaction mixture was allowed to cool to room
temperature and then poured into cold water (100 mL). The solid
product was filtered, washed with EtOH (95%). The product was
purified by column chromatography (silica gel, 200–300 mesh, PE–
acetone, 4:1) to give (7b). 4-(4-Chlorophenyl)-2-(1H-indol-3-yl)benzo-
[h]quinoline-3-carbonitrile: Brown solid; mp: >300 °C; IR (KBr): m
3252, 3058, 2979, 2187, 1608, 1519, 1479, 1399, 1241, 951, 807, 755,
17. (a) Ji, S.-J.; Wang, S.-Y.; Zhang, Y.; Loh, T.-P. Tetrahedron 2004, 60,
2051; (b) Gu, D.-G.; Ji, S.-J.; Jiang, Z.-Q.; Zhou, M.-F.; Loh, T.-P.
Synlett 2005, 959; (c) Wang, S.-Y.; Ji, S.-J. Tetrahedron 2006, 62,
1527; (d) Wang, S.-Y.; Ji, S.-J. Synlett 2007, 2222; (e) Zhu, S.-L.; Ji,
S.-J.; Zhang, Y. Tetrahedron 2007, 63, 9365.
´
18. (a) Quiroga, J.; Insuasty, B.; Hormaza, A.; Gamenara, D.; Domın-
guez, L.; Saldana, J. J. Heterocycl. Chem. 1999, 36, 1311; (b) Quiroga,
J.; Cruz, S.; Insuasty, B.; Abonia, R.; Nogueras, M.; Sanchez, A.;
Cobo, J.; Low, J. N. J. Heterocycl. Chem. 2001, 38, 53; (c) Zhu, S.-L.;
Tu, S.-J.; Li, T.-J.; Zhang, X.-J.; Ji, S.-J.; Zhang, Y. Chin. J. Org.
Chem. 2005, 25, 987.
19. Typical experimental procedure:
600 cmꢀ1 1H NMR (400 MHz, DMSO-d6): d 11.86 (br s, 1H, NH),
;
Preparation of compound 4a under MW condition: The reaction was
performed in a monomodal EmrysTM Creator from Personal Chem-
istry, Uppsala, Sweden. In a 10 mL EmrysTM reaction vial, 3-cyano-
acetyl indole (1 mmol), 4-chlorobenzaldehyde (1 mmol), 3-methyl-1-
phenyl-1H-pyrazol-5-amine 3 (1 mmol) and glycol (2 mL) were mixed
and then capped. The mixture was irradiated for the given time at the
maximum power of 250 W and 150 °C. Upon completion, monitored
by TLC, the reaction mixture was allowed to cool to room
temperature and then poured into cold water (100 mL). The solid
product was filtered, washed with EtOH (95%). The product was
9.35 (d, J = 10.0 Hz, 1H), 8.68 (d, J = 10.4 Hz, 1H), 8.45 (s, 1H,
Indolyl-H), 8.07–8.09 (m, 2H), 7.88–7.90 (m, 4H), 7.33–7.52 (m, 6H);
13C NMR (100 MHz, DMSO-d6): d 153.4, 152.9, 149.8, 138.3, 136.4,
134.8, 132.6, 132.4, 130.6, 129.2, 128.8, 128.5, 127.8, 127.0, 126.8,
126.5, 126.1, 122.9, 122.4, 122.2, 120.7, 119.2, 118.2, 112.2, 111.9,
104.5; HRMS found: m/z 429.1019 (M+), calcd for C28H16N3Cl: M,
429.1033.
20. Crystallographic data for the structures of 4a and 7d reported in this
paper have been deposited at the Cambridge Crystallographic Data
Centre with No. CCDC-632865 and 631307, respectively.